SRF Postdoctoral Fellowship supports early-career scientists exploring how scleroderma develops and testing innovative, hypothesis-driven therapeutic strategies to advance research on the disease.
Funder: Scleroderma Research Foundation
Due Dates (Anticipated): March 2027 (New Grant Applications)
Funding Amounts: $35,000–$55,000 per year for two years; up to two fellowships
Summary: Supports postdoctoral scientists developing new hypotheses on scleroderma pathogenesis and innovative, hypothesis-driven therapeutic approaches.
Key Information: Applicants must be US citizens or permanent residents and secure a research sponsor at a public or private nonprofit institution.
The Scleroderma Research Foundation (SRF) Postdoctoral Fellowship brings talented early-career scientists into scleroderma research. It supports fellows with strong records of accomplishment and a clear research direction or novel ideas they wish to develop. The program particularly encourages new approaches and hypotheses for understanding how scleroderma arises and develops, alongside the design, development, and pilot testing of hypothesis-driven, innovative therapeutic strategies.
The fellowship is part of SRF’s broader effort to advance research through collaboration and cross-institutional cooperation among scientists from different disciplines. Its priorities include attracting promising scientists, maintaining Scleroderma Centers of Excellence, and bringing new technologies and thinking into the field. SRF welcomes scientists new to scleroderma as well as those already working extensively on the disease.